|Top Industry Values
Celgene rank is 28
|Top Intrinsic Values
Celgene rank is 188
The average analysts' target price is $131.00 for Celgene using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Celgene is ranked 314.
Celgene has a PEG Value of $173.64. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 69.16% in the next year. Among companies with a PEG Value above the current stock price, Celgene is ranked 380.
The StockSelector Value for Celgene is $170.70. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Celgene is ranked 475.
Celgene rank is 703
|Up Estimate Revision
During the past month, the consensus earnings estimate for the current year and next year have increased by a combined 0.88%. Among companies that have had their estimates raised within the past month, Celgene is ranked 893.
|Up EPS Surprise
Celgene beat the consensus earnings estimate when it last reported quarterly earnings.
|Down Ratings Revision
During the past month, the average analyst's rating or recommendation has decreased. Among companies that have been downgraded within the past month, Celgene is ranked 25.
According to EarningsWhispers.com, Celgene missed the Earnings Whisper ® number when it last reported earnings. Statistics show that companies that have missed the Earnings Whisper ® number underperform the market in the short-term.
|90 Day Loss
Celgene rank is 398
|10 Day Loss
Celgene rank is 852
Celgene has a high Put/Call ratio of 0.68 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Celgene is ranked 1362.
Celgene has a high Put/Call ratio of 0.78 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Celgene is ranked 1643.